Transforming Our Discoveries Into Therapeutics
The Technology Transfer Office embodies the spirit of the National Jewish Health brand promise, Breathing Science is Life®. We accelerate the development of basic scientific research toward clinical application by identifying and protecting the institution's intellectual property and facilitating business partnerships for technology development, licensing, and commercialization.
National Jewish Health currently has in its portfolio:
175 active technologies developed from our research
95 active U.S. patents protecting these technologies
50 percent of those active US patents are licensed to biotechnology companies for the development of therapeutics
Additionally, in the 25 years since the Technology Transfer Office was created, National Jewish Health has:
executed 328 license agreements, of which 165 are still active;
executed a total of 2,708 material transfer agreements; and
helped create 11 start-up companies.
Technologies from National Jewish Health
To browse a list of the technologies ready for licensing or further development, select one of the following:
Featured Technology: Selenocyanate as Antimicrobial Against Lung Infections
Staff | Contact Information |
Emmanuel Hilaire, PhD Director Phone: 303.398.1262 HilaireE@njhealth.org Susana Cestino Read, DVM, MBA Licensing Manager Phone: 303.270.2871 CestinoReadS@njhealth.org | National Jewish Health Technology Transfer Office 1400 Jackson St., M206 Denver, CO 80206 Fax: 303.270.2352 |